Review on flavivirus vaccine development

Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand

J. Hombach, Alan Barrett, M. J. Cardosa, V. Deubel, M. Guzman, I. Kurane, J. T. Roehrig, A. Sabchareon, M. P. Kieny

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

In light of the continuous spread of human pathogenic flaviviruses, in particular the mosquito-transmitted species, vaccine development remains a high priority on the public health agenda. On 26-27 April 2004, a conference was held in Bangkok, Thailand, to review current status of flavivirus vaccine development and related issues, focussing on dengue (DEN) and Japanese encephalitis (JE). This event, co-sponsored by the World Health Organization (WHO) and the Thai Ministry of Public Health, reviewed the progress made with vaccine development, sero-epidemiological studies and other accompanying activities critical for vaccine development and vaccination. The considerable interest in and awareness of the flavivirus diseases and their prevention by public health decision makers, as well as the establishment of two dedicated programmes for dengue and Japanese encephalitis vaccine development raise hopes that new or improved vaccines will become available in the coming years.

Original languageEnglish (US)
Pages (from-to)2689-2695
Number of pages7
JournalVaccine
Volume23
Issue number21
DOIs
StatePublished - Apr 15 2005
Externally publishedYes

Fingerprint

Flavivirus
vaccine development
World Health Organization
Thailand
public health
Vaccines
Public Health
dengue
Dengue
encephalitis
Japanese Encephalitis Vaccines
Flaviviridae
Japanese Encephalitis
serological surveys
Culicidae
Epidemiologic Studies
Vaccination
vaccination
vaccines

Keywords

  • Flavivirus vaccine
  • Human pathogenic flaviviruses
  • Sero-epidemiological studies

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Review on flavivirus vaccine development : Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand. / Hombach, J.; Barrett, Alan; Cardosa, M. J.; Deubel, V.; Guzman, M.; Kurane, I.; Roehrig, J. T.; Sabchareon, A.; Kieny, M. P.

In: Vaccine, Vol. 23, No. 21, 15.04.2005, p. 2689-2695.

Research output: Contribution to journalArticle

Hombach, J. ; Barrett, Alan ; Cardosa, M. J. ; Deubel, V. ; Guzman, M. ; Kurane, I. ; Roehrig, J. T. ; Sabchareon, A. ; Kieny, M. P. / Review on flavivirus vaccine development : Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand. In: Vaccine. 2005 ; Vol. 23, No. 21. pp. 2689-2695.
@article{d38af96d22b94210a0cc6a3621fbb826,
title = "Review on flavivirus vaccine development: Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand",
abstract = "In light of the continuous spread of human pathogenic flaviviruses, in particular the mosquito-transmitted species, vaccine development remains a high priority on the public health agenda. On 26-27 April 2004, a conference was held in Bangkok, Thailand, to review current status of flavivirus vaccine development and related issues, focussing on dengue (DEN) and Japanese encephalitis (JE). This event, co-sponsored by the World Health Organization (WHO) and the Thai Ministry of Public Health, reviewed the progress made with vaccine development, sero-epidemiological studies and other accompanying activities critical for vaccine development and vaccination. The considerable interest in and awareness of the flavivirus diseases and their prevention by public health decision makers, as well as the establishment of two dedicated programmes for dengue and Japanese encephalitis vaccine development raise hopes that new or improved vaccines will become available in the coming years.",
keywords = "Flavivirus vaccine, Human pathogenic flaviviruses, Sero-epidemiological studies",
author = "J. Hombach and Alan Barrett and Cardosa, {M. J.} and V. Deubel and M. Guzman and I. Kurane and Roehrig, {J. T.} and A. Sabchareon and Kieny, {M. P.}",
year = "2005",
month = "4",
day = "15",
doi = "10.1016/j.vaccine.2004.11.040",
language = "English (US)",
volume = "23",
pages = "2689--2695",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "21",

}

TY - JOUR

T1 - Review on flavivirus vaccine development

T2 - Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand

AU - Hombach, J.

AU - Barrett, Alan

AU - Cardosa, M. J.

AU - Deubel, V.

AU - Guzman, M.

AU - Kurane, I.

AU - Roehrig, J. T.

AU - Sabchareon, A.

AU - Kieny, M. P.

PY - 2005/4/15

Y1 - 2005/4/15

N2 - In light of the continuous spread of human pathogenic flaviviruses, in particular the mosquito-transmitted species, vaccine development remains a high priority on the public health agenda. On 26-27 April 2004, a conference was held in Bangkok, Thailand, to review current status of flavivirus vaccine development and related issues, focussing on dengue (DEN) and Japanese encephalitis (JE). This event, co-sponsored by the World Health Organization (WHO) and the Thai Ministry of Public Health, reviewed the progress made with vaccine development, sero-epidemiological studies and other accompanying activities critical for vaccine development and vaccination. The considerable interest in and awareness of the flavivirus diseases and their prevention by public health decision makers, as well as the establishment of two dedicated programmes for dengue and Japanese encephalitis vaccine development raise hopes that new or improved vaccines will become available in the coming years.

AB - In light of the continuous spread of human pathogenic flaviviruses, in particular the mosquito-transmitted species, vaccine development remains a high priority on the public health agenda. On 26-27 April 2004, a conference was held in Bangkok, Thailand, to review current status of flavivirus vaccine development and related issues, focussing on dengue (DEN) and Japanese encephalitis (JE). This event, co-sponsored by the World Health Organization (WHO) and the Thai Ministry of Public Health, reviewed the progress made with vaccine development, sero-epidemiological studies and other accompanying activities critical for vaccine development and vaccination. The considerable interest in and awareness of the flavivirus diseases and their prevention by public health decision makers, as well as the establishment of two dedicated programmes for dengue and Japanese encephalitis vaccine development raise hopes that new or improved vaccines will become available in the coming years.

KW - Flavivirus vaccine

KW - Human pathogenic flaviviruses

KW - Sero-epidemiological studies

UR - http://www.scopus.com/inward/record.url?scp=15044359108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15044359108&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2004.11.040

DO - 10.1016/j.vaccine.2004.11.040

M3 - Article

VL - 23

SP - 2689

EP - 2695

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 21

ER -